LEMAITRE VASCULAR INC

For the period ended Sep 30, 2024. Filed Nov 8, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 8, 2024

LMAT$80.89-3.1%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

LEMAITRE VASCULAR

FORM 10-Q

TABLE OF CONTENTS

Page
Part I.	Financial Information:	4
	Item 1.	Financial Statements	4
		Consolidated Balance Sheets as of September 30, 2024 (unaudited) and December 31, 2023	4
		Unaudited Consolidated Statements of Operations for the three-month and nine-month periods ended September 30, 2024 and 2023	5
		Unaudited Consolidated Statements of Comprehensive Income for the three-month and nine-month periods ended September 30, 2024 and 2023	6
		Unaudited Consolidated Statements of Stockholders’ Equity for the three-month and nine-month periods ended September 30, 2024 and 2023	7
		Unaudited Consolidated Statements of Cash Flows for the nine-month periods ended September 30, 2024 and 2023	9
		Notes to Unaudited Consolidated Financial Statements	10
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
	Item 3.	Quantitative and Qualitative Disclosure about Market Risk	29
	Item 4.	Controls and Procedures	29
Part II.	Other Information:	31
	Item 1.	Legal Proceedings	31
	Item 1A.	Risk Factors	31
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
	Item 5.	Other Information	31
	Item 6.	Exhibits	32
	Signatures	33

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents